文献速递免疫规划妇幼与学校卫生

妊娠期无意接种炭疽疫苗的安全性:2003-2010年美国军人人群出生缺陷分析

Safety of inadvertent anthrax vaccination during pregnancy: An analysis of birth defects in the U.S. military population, 2003-2010.
PubMed 文献 · Vaccine · 2017-06-30

研究纳入国防部出生与婴儿健康登记处2003-2010年126,839名活产婴儿,按母亲炭疽疫苗吸附(AVA)接种时间与妊娠的关系分组,评估婴儿1岁内出生缺陷诊断。多变量逻辑回归显示,妊娠期无意接种AVA与出生缺陷风险无明显强关联;与产后接种相比,孕前接种者出生缺陷比值略高(OR 1.11,95%CI 1.01-1.22),从未接种者比值略低(OR 0.90,95%CI 0.83-0.99)。

要点

  • 孕早期接种AVA者与其他时间点接种者相比,出生缺陷比值无显著差异(OR 1.10,95%CI 0.93-1.29)。
  • 与产后接种相比,孕前接种者出生缺陷比值略高(OR 1.11,95%CI 1.01-1.22)。
  • 与从未接种相比,产后接种者出生缺陷比值低10%(OR 0.90,95%CI 0.83-0.99)。

核心结论

  • 妊娠期无意接种AVA与出生缺陷风险未见强关联,孕前接种或从未接种与产后接种相比仅见边缘关联。
  • 作者认为与产后接种比较时的边缘关联可能源于自我选择和/或反向因果偏倚,与从未接种女性比较时可能源于健康工人效应。

研究设计与样本

  • 研究为基于美国国防部出生与婴儿健康登记处(2003-2010年)的分析,纳入126,839名活产婴儿。
  • 母亲按AVA接种时间与妊娠的关系分类,婴儿病历评估1岁内出生缺陷诊断,采用多变量逻辑回归计算OR及95%CI。

主要发现

  • 孕早期接种AVA母亲所生婴儿与其他时间点接种者所生婴儿相比,校正后出生缺陷比值无显著差异(OR 1.10,95%CI 0.93-1.29)。
  • 孕前接种与孕后接种相比,出生缺陷比值升高(OR 1.11,95%CI 1.01-1.22)。
  • 孕后接种与从未接种相比,出生缺陷比值降低10%(OR 0.90,95%CI 0.83-0.99)。

关键数值与推荐

  • 孕早期接种AVA与其他时间点接种比较:OR 1.10(95%CI 0.93-1.29)。
  • 孕前接种与孕后接种比较:OR 1.11(95%CI 1.01-1.22)。
  • 孕后接种与从未接种比较:OR 0.90(95%CI 0.83-0.99)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出,与产后接种比较时的边缘关联可能源于自我选择和/或反向因果偏倚。
  • 作者指出,与从未接种女性比较时的边缘关联可能源于健康工人效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anthrax vaccine adsorbed (AVA) vaccination is compulsory for United States military servicemembers with operational indicators. As the number of female military servicemembers has increased, so has the chance of inadvertent AVA vaccination during pregnancy. Building upon past analyses assessing AVA vaccination during pregnancy and birth defects risk, this study sought to determine if inadvertent AVA vaccination during pregnancy is significantly associated with risk of birth defects after adjusting for other potential risk factors. METHODS: The study population included 126,839 liveborn infants in the Department of Defense Birth and Infant Health Registry (2003-2010). Mothers were categorized by AVA vaccination exposure timing in relation to pregnancy. Infant medical records were assessed for birth defect diagnoses within the first year of life. Multivariable logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: Infants of first trimester AVA vaccinated mothers versus receipt at any other time point (OR, 1.10; 95% CI, 0.93-1.29) were not at higher odds of birth defects in adjusted models. Infants of mothers vaccinated prepregnancy versus postpregnancy had a 1.11 (95% CI, 1.01-1.22) higher odds of having a birth defect. Vaccination postpregnancy versus never vaccinated revealed a 10% lower odds of birth defects (OR, 0.90; 95% CI, 0.83-0.99). CONCLUSIONS: No strong associations between inadvertent AVA vaccination during pregnancy and birth defects risk were observed. Marginal associations between prepregnancy vaccination or never vaccinated women and birth defects risk was observed when compared to postpregnancy vaccination. These findings may be due to self-selection and/or reverse causation bias when assessing comparisons with postpregnancy vaccination, and a "healthy worker" effect when assessing comparisons with women never vaccinated.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Conlin AMS, Sevick CJ, Gumbs GR, et al. Safety of inadvertent anthrax vaccination during pregnancy: An analysis of birth defects in the U.S. military population, 2003-2010. Vaccine. 2017. PMID: 28673484. doi:10.1016/j.vaccine.2017.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。